Results 71 to 80 of about 1,640,336 (314)

Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020

open access: gold, 2023
Nirosha D. Perera   +19 more
openalex   +1 more source

Humanized mouse models for immuno-oncology research

open access: yesNature Reviews Clinical Oncology, 2023
Jane Chuprin   +7 more
semanticscholar   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

open access: yesMolecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster   +3 more
wiley   +1 more source

Tumor‐agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell‐free DNA fragmentomics

open access: yesMolecular Oncology, EarlyView.
We evaluated circulating tumor DNA (ctDNA) detection in advanced pancreatic cancer using DNA methylation, cell‐free DNA fragment lengths, and 5′ end motifs. Machine learning models were trained to estimate ctDNA levels from each feature and their combination.
Morten Lapin   +10 more
wiley   +1 more source

Experiences of young adults affected by cancer within an 8-week yoga intervention delivered by videoconference: a qualitative interview study

open access: yesAnnals of Medicine
Background Yoga may reduce negative cancer- and treatment-related effects and help improve a range of outcomes, including flexibility, mindfulness, and quality of life among adults affected by cancer.
Emma McLaughlin   +6 more
doaj   +1 more source

Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients [PDF]

open access: hybrid, 2006
Mary O’Brien   +9 more
openalex   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

open access: yesMolecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy